$ADPT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adaptive Biotechnologies Corp. Get notifications about new insider transactions in Adaptive Biotechnologies Corp for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 11 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.32 | 1,853 | 113,626 | 0 | 1.9 K to 0 (-100.00 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.12 | 1,700 | 102,204 | 0 | 1.7 K to 0 (-100.00 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.72 | 6,922 | 420,304 | 1,853 | 8.8 K to 1.9 K (-78.88 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.55 | 13,300 | 792,015 | 1,700 | 15 K to 1.7 K (-88.67 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.48 | 6,225 | 370,263 | 8,775 | 15 K to 8.8 K (-41.50 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.32 | 1,853 | 113,626 | 0 | 1.9 K to 0 (-100.00 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.95 | 200 | 12,790 | 0 | 200 to 0 (-100.00 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.72 | 6,922 | 420,304 | 1,853 | 8.8 K to 1.9 K (-78.88 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.33 | 2,258 | 142,999 | 200 | 2.5 K to 200 (-91.86 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.48 | 6,225 | 370,263 | 8,775 | 15 K to 8.8 K (-41.50 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.04 | 3,735 | 231,719 | 2,458 | 6.2 K to 2.5 K (-60.31 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.89 | 8,807 | 536,258 | 6,193 | 15 K to 6.2 K (-58.71 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.95 | 200 | 12,790 | 0 | 200 to 0 (-100.00 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.33 | 2,258 | 142,999 | 200 | 2.5 K to 200 (-91.86 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.04 | 3,735 | 231,719 | 2,458 | 6.2 K to 2.5 K (-60.31 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.89 | 8,807 | 536,258 | 6,193 | 15 K to 6.2 K (-58.71 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 28 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 440,000 | |
| Dec 28 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 65.39 | 378 | 24,717 | 0 | 378 to 0 (-100.00 %) |
| Dec 28 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 64.29 | 3,741 | 240,509 | 378 | 4.1 K to 378 (-90.82 %) |
| Dec 28 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.71 | 7,394 | 471,072 | 4,119 | 11.5 K to 4.1 K (-64.22 %) |
| Dec 28 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.15 | 3,487 | 216,717 | 11,513 | 15 K to 11.5 K (-23.25 %) |
| Dec 28 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 455,000 | |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 470,000 | |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 485,000 | |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 65.41 | 1,029 | 67,307 | 0 | 1 K to 0 (-100.00 %) |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 64.59 | 5,506 | 355,633 | 1,029 | 6.5 K to 1 K (-84.25 %) |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.90 | 8,465 | 540,914 | 6,535 | 15 K to 6.5 K (-56.43 %) |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 64.36 | 1,900 | 122,284 | 0 | 1.9 K to 0 (-100.00 %) |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.62 | 13,100 | 833,422 | 1,900 | 15 K to 1.9 K (-87.33 %) |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.72 | 7,323 | 437,330 | 0 | 7.3 K to 0 (-100.00 %) |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.15 | 7,677 | 454,095 | 7,323 | 15 K to 7.3 K (-51.18 %) |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Option Exercise | M | 0.84 | 57,000 | 47,880 | 2,000 | |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 64.06 | 20,486 | 1,312,333 | 10,000 | 30.5 K to 10 K (-67.20 %) |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 63.52 | 36,514 | 2,319,369 | 30,486 | 67 K to 30.5 K (-54.50 %) |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Buy | M | 0.84 | 57,000 | 47,880 | 67,000 | 10 K to 67 K (+570.00 %) |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | Pellini Michael J | Director | Option Exercise | M | 6.55 | 25,000 | 163,750 | 75,000 | |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | Pellini Michael J | Director | Sell | S | 60.00 | 25,000 | 1,500,000 | 0 | 25 K to 0 (-100.00 %) |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | Pellini Michael J | Director | Buy | M | 6.55 | 25,000 | 163,750 | 25,000 | 0 to 25 K |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 417 | 2,615 | 1,667 | |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 59.14 | 417 | 24,661 | 0 | 417 to 0 (-100.00 %) |
| Dec 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 417 | 2,615 | 417 | 0 to 417 |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Option Exercise | M | 0.84 | 40,000 | 33,600 | 59,000 | |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 59.00 | 40,000 | 2,360,000 | 10,000 | 50 K to 10 K (-80.00 %) |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Buy | M | 0.84 | 40,000 | 33,600 | 50,000 | 10 K to 50 K (+400.00 %) |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 59,000 | |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 57.01 | 241 | 13,739 | 0 | 241 to 0 (-100.00 %) |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 55.78 | 1,759 | 98,117 | 241 | 2 K to 241 (-87.95 %) |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | M | 7.80 | 6,000 | 46,800 | 101,000 | |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 59.44 | 1,651 | 98,135 | 0 | 1.7 K to 0 (-100.00 %) |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 58.96 | 3,367 | 198,518 | 1,651 | 5 K to 1.7 K (-67.10 %) |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 57.42 | 982 | 56,386 | 5,018 | 6 K to 5 K (-16.37 %) |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Buy | M | 7.80 | 6,000 | 46,800 | 6,000 | 0 to 6 K |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Option Exercise | M | 7.80 | 2,000 | 15,600 | 161,000 | |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 57.01 | 241 | 13,739 | 0 | 241 to 0 (-100.00 %) |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 55.79 | 1,759 | 98,135 | 241 | 2 K to 241 (-87.95 %) |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Buy | M | 7.80 | 2,000 | 15,600 | 2,000 | 0 to 2 K |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Sell | S | 55.65 | 1,000,000 | 55,650,000 | 29,993,708 | 31 M to 30 M (-3.23 %) |
| Dec 11 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, External Affai ... | Option Exercise | M | 6.55 | 50,000 | 327,500 | 155,000 | |
| Dec 11 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, External Affai ... | Sell | S | 56.13 | 50,000 | 2,806,500 | 0 | 50 K to 0 (-100.00 %) |
| Dec 11 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, External Affai ... | Buy | M | 6.55 | 50,000 | 327,500 | 50,000 | 0 to 50 K |
| Dec 11 2020 | ADPT | Adaptive Biotechno ... | BOBULSKY SUSAN | SVP, Diagnostics, c ... | Option Exercise | M | 1.98 | 25,000 | 49,500 | 30,000 | |
| Dec 11 2020 | ADPT | Adaptive Biotechno ... | BOBULSKY SUSAN | SVP, Diagnostics, c ... | Sell | S | 55.00 | 25,000 | 1,375,000 | 0 | 25 K to 0 (-100.00 %) |
| Dec 11 2020 | ADPT | Adaptive Biotechno ... | BOBULSKY SUSAN | SVP, Diagnostics, c ... | Buy | M | 1.98 | 25,000 | 49,500 | 25,000 | 0 to 25 K |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Option Exercise | M | 7.80 | 6,250 | 48,750 | 381,250 | |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 51.26 | 2,470 | 126,612 | 0 | 2.5 K to 0 (-100.00 %) |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 50.14 | 3,000 | 150,420 | 2,470 | 5.5 K to 2.5 K (-54.84 %) |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 48.79 | 780 | 38,056 | 5,470 | 6.3 K to 5.5 K (-12.48 %) |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Buy | M | 7.80 | 6,250 | 48,750 | 6,250 | 0 to 6.3 K |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 30,000 | 189,600 | 490,000 | |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 52.38 | 300 | 15,714 | 1,000 | 1.3 K to 1,000 (-23.08 %) |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 51.98 | 9,444 | 490,899 | 1,300 | 10.7 K to 1.3 K (-87.90 %) |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 50.88 | 20,256 | 1,030,625 | 10,744 | 31 K to 10.7 K (-65.34 %) |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 30,000 | 189,600 | 31,000 | 1,000 to 31 K (+3,000.00 %) |
| Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,562 | 11,356 | 39,063 | |
| Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 57,292 | |
| Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 28,646 | |
| Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 49.43 | 3,693 | 182,545 | 0 | 3.7 K to 0 (-100.00 %) |
| Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 48.20 | 3,077 | 148,311 | 3,693 | 6.8 K to 3.7 K (-45.45 %) |
| Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,562 | 11,356 | 6,770 | 5.2 K to 6.8 K (+29.99 %) |
| Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
| Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
| Nov 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 416 | 2,608 | 2,084 | |
| Nov 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 48.86 | 416 | 20,326 | 0 | 416 to 0 (-100.00 %) |
| Nov 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 416 | 2,608 | 416 | 0 to 416 |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 49,560 | |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 66,240 | |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 82,920 | |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.54 | 900 | 43,686 | 1,778,180 | 1.8 M to 1.8 M (-0.05 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.75 | 4,360 | 208,190 | 1,779,080 | 1.8 M to 1.8 M (-0.24 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.69 | 3,773 | 176,161 | 1,783,440 | 1.8 M to 1.8 M (-0.21 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 49,560 | |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.60 | 7,647 | 348,703 | 1,787,213 | 1.8 M to 1.8 M (-0.43 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 66,240 | |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 82,920 | |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.52 | 13,480 | 654,050 | 1,778,180 | 1.8 M to 1.8 M (-0.75 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.54 | 900 | 43,686 | 1,778,180 | 1.8 M to 1.8 M (-0.05 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.64 | 2,000 | 95,280 | 1,791,660 | 1.8 M to 1.8 M (-0.11 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.75 | 4,360 | 208,190 | 1,779,080 | 1.8 M to 1.8 M (-0.24 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.68 | 1,200 | 56,016 | 1,793,660 | 1.8 M to 1.8 M (-0.07 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.69 | 3,773 | 176,161 | 1,783,440 | 1.8 M to 1.8 M (-0.21 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.60 | 7,647 | 348,703 | 1,787,213 | 1.8 M to 1.8 M (-0.43 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.68 | 5,633 | 262,948 | 1,778,180 | 1.8 M to 1.8 M (-0.32 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.84 | 11,047 | 506,394 | 1,783,813 | 1.8 M to 1.8 M (-0.62 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.52 | 13,480 | 654,050 | 1,778,180 | 1.8 M to 1.8 M (-0.75 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.64 | 2,000 | 95,280 | 1,791,660 | 1.8 M to 1.8 M (-0.11 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.68 | 1,200 | 56,016 | 1,793,660 | 1.8 M to 1.8 M (-0.07 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.68 | 5,633 | 262,948 | 1,778,180 | 1.8 M to 1.8 M (-0.32 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.84 | 11,047 | 506,394 | 1,783,813 | 1.8 M to 1.8 M (-0.62 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Nov 13 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Sell | S | 49.52 | 2,500,000 | 123,787,500 | 30,993,708 | 33.5 M to 31 M (-7.46 %) |
| Nov 13 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Sell | S | 49.52 | 2,500,000 | 123,787,500 | 30,993,708 | 33.5 M to 31 M (-7.46 %) |
| Nov 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 30,000 | 189,600 | 520,000 | |
| Nov 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 50.92 | 1,760 | 89,619 | 1,000 | 2.8 K to 1,000 (-63.77 %) |
| Nov 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 49.63 | 11,089 | 550,347 | 2,760 | 13.8 K to 2.8 K (-80.07 %) |
| Nov 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 48.67 | 17,151 | 834,739 | 13,849 | 31 K to 13.8 K (-55.33 %) |
| Nov 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 30,000 | 189,600 | 31,000 | 1,000 to 31 K (+3,000.00 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 233,700 | |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 244,800 | |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 255,900 | |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 52.50 | 900 | 47,250 | 679 | 1.6 K to 679 (-57.00 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 51.57 | 8,700 | 448,659 | 1,579 | 10.3 K to 1.6 K (-84.64 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 50.48 | 1,500 | 75,720 | 10,279 | 11.8 K to 10.3 K (-12.73 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 50.88 | 3,846 | 195,684 | 679 | 4.5 K to 679 (-84.99 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 50.00 | 7,254 | 362,700 | 4,525 | 11.8 K to 4.5 K (-61.58 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 50.98 | 1,300 | 66,274 | 679 | 2 K to 679 (-65.69 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 50.20 | 9,800 | 491,960 | 1,979 | 11.8 K to 2 K (-83.20 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,563 | 11,363 | 40,625 | |
| Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 59,896 | |
| Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,605 | 17,063 | 31,250 | |
| Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 46.14 | 1,074 | 49,554 | 0 | 1.1 K to 0 (-100.00 %) |
| Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 45.47 | 5,698 | 259,088 | 1,074 | 6.8 K to 1.1 K (-84.14 %) |
| Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,563 | 11,363 | 6,772 | 5.2 K to 6.8 K (+30.01 %) |